N Engl J Med 375(19):18341844 Zinman B, Bhosekar V, Busch R, Holst I, Ludvik B, Thielke D et al (2019) Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
Dihexa offers a range of potential cognitive benefits: Dihexa may be suitable for adults experiencing cognitive decline or those seeking to optimize their mental performance
This includes: Patients with malabsorption issues due to gastrointestinal disorders Individuals with pernicious anemia or other conditions that impair B12 absorption Cases where a rapid increase in B12 levels is necessary In these cases, IV delivery gets B12 straight into the blood
The peptide upregulates expression of epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor among others
The high followed the ADA retatrutide readout